Literature DB >> 2726742

Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

R Clarke1, N Brünner, B S Katzenellenbogen, E W Thompson, M J Norman, C Koppi, S Paik, M E Lippman, R B Dickson.   

Abstract

We have isolated a series of sublines of the hormone-dependent MCF-7 human breast cancer cell line after selection both in vivo and in vitro for growth in the presence of subphysiological concentrations of estrogens. These sublines represent a model system for study of the processes leading to hormonal autonomy. The cells form growing tumors in ovariectomized athymic nude mice in the absence of estrogen supplementation but retain some responsivity to estrogen as determined by stimulation of the rate of tumor growth in vivo and by induction of progesterone receptor. An ovarian-independent but hormone-responsive phenotype may occur early in the natural progression to hormone-independent and unresponsive growth in breast cancer. We observed no change in the affinity or decrease in the level of expression of estrogen receptors and progesterone receptors among the sublines and the parental cells. Epidermal growth factor receptors are not overexpressed in ovarian-independent cells. Thus, altered hormone receptor expression may be a late event in the acquisition of a hormone-independent and unresponsive phenotype. Sublines isolated by in vivo but not in vitro selection are more invasive than the parental cells both in vivo and across an artificial basement membrane in vitro. Thus, as yet unknown tumor-host interactions may be important in the development of an invasive phenotype. Furthermore, acquisition of the ovarian-independent and invasive phenotypes can occur independently.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2726742      PMCID: PMC287195          DOI: 10.1073/pnas.86.10.3649

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  The control of hormone-dependent breast cancer growth--are we talking about estrogen alone?

Authors:  V C Jordan
Journal:  Eur J Cancer Clin Oncol       Date:  1988-08

2.  The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo.

Authors:  R Clarke; N Brünner; D Katz; P Glanz; R B Dickson; M E Lippman; F G Kern
Journal:  Mol Endocrinol       Date:  1989-02

3.  Estrogen receptor content and hormone-responsive growth of mouse mammary tumors.

Authors:  M Sluyser; R Van Nie
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

4.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

5.  Changes in multiple or sequential estrogen receptor determinations in breast cancer.

Authors:  J C Allegra; A Barlock; K K Huff; M E Lippman
Journal:  Cancer       Date:  1980-02-15       Impact factor: 6.860

6.  Progression from hormone dependence to autonomy in mammary tumors as an in vivo manifestation of sequential clonal selection.

Authors:  U Kim; M J Depowski
Journal:  Cancer Res       Date:  1975-08       Impact factor: 12.701

7.  Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice.

Authors:  H D Soule; C M McGrath
Journal:  Cancer Lett       Date:  1980-08       Impact factor: 8.679

8.  A reassessment of the role of breast tumor aromatization.

Authors:  H L Bradlow
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

9.  Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.

Authors:  N E Davidson; E P Gelmann; M E Lippman; R B Dickson
Journal:  Mol Endocrinol       Date:  1987-03

10.  Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice.

Authors:  S M Shafie; F H Grantham
Journal:  J Natl Cancer Inst       Date:  1981-07       Impact factor: 13.506

View more
  45 in total

1.  Multilevel support vector regression analysis to identify condition-specific regulatory networks.

Authors:  Li Chen; Jianhua Xuan; Rebecca B Riggins; Yue Wang; Eric P Hoffman; Robert Clarke
Journal:  Bioinformatics       Date:  2010-04-07       Impact factor: 6.937

2.  Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cells.

Authors:  Chun Chen; William T Baumann; Robert Clarke; John J Tyson
Journal:  FEBS Lett       Date:  2013-08-28       Impact factor: 4.124

3.  The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential.

Authors:  Tammy A Castro; Marion C Cohen; Pranela Rameshwar
Journal:  Clin Exp Metastasis       Date:  2006-04-27       Impact factor: 5.150

4.  2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells.

Authors:  D C Spink; D W Lincoln; H W Dickerman; J F Gierthy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence.

Authors:  M A Christine Pratt; Tanya E Bishop; Dawn White; Gordon Yasvinski; Michel Ménard; Min Ying Niu; Robert Clarke
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

6.  MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo.

Authors:  Y Liu; D el-Ashry; D Chen; I Y Ding; F G Kern
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

7.  Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Authors:  Robert Clarke; Ayesha N Shajahan; Rebecca B Riggins; Younsook Cho; Anatasha Crawford; Jianhua Xuan; Yue Wang; Alan Zwart; Ruchi Nehra; Minetta C Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03       Impact factor: 4.292

8.  Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.

Authors:  Sudipan Karmakar; Estrella A Foster; Carolyn L Smith
Journal:  Endocrinology       Date:  2008-12-18       Impact factor: 4.736

9.  The nude mouse as an in vivo model for human breast cancer invasion and metastasis.

Authors:  N Brünner; B Boysen; J Rømer; M Spang-Thomsen
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and the actions of antiestrogens.

Authors:  J C Reese; B S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.